COMP <GO>
HRMY vs SDGR // EV/EBITDA & P/E VALUATION
Harmony Biosciences Holdings Inc. (NASDAQ) VS. Schrodinger Inc. (NASDAQ) • 15-METRIC TALLY: HRMY 8
— SDGR 2
■ METRIC PARITY
LAST: $38.59 (+0.23%) • MKT CAP: $2.25B
valuation
7.8x
LAST: $29.99 (-2.85%) • MKT CAP: $2.24B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HRMY VS. SDGR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HRMY | SDGR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 77.20% | 55.70% | +21.50 | HRMY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 63.00% | -35.00% | +98.00 | HRMY | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 7.8x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 15.48% | 0.56% | +14.92 | HRMY | /fcf-yield <GO> |
| Operating Margin | 24.00% | -60.00% | +84.00 | HRMY | /operating-margins <GO> |
| Net Profit Margin | 18.30% | -40.40% | +58.70 | HRMY | /net-margins <GO> |
| Revenue Growth (YoY) | 21.50% | 23.30% | -1.80 | SDGR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.38 | 2.64 | +2.74 | HRMY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | HRMY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.1 | 53.0 | -1.89 | SDGR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 11.9x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.25B | $2.24B | $3.9M | HRMY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HRMY REV | SDGR REV | HRMY GROSS % | SDGR GROSS % | HRMY FCF | SDGR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $868.5M | $255.9M | 77.2% | 55.7% | $347.9M | $12.5M |
| FY 2024 | $714.7M | $207.5M | 78.1% | 63.6% | $218.7M | -$164.7M |
| FY 2023 | $582.0M | $216.7M | — | — | $219.4M | -$136.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HRMY // BETA —
SDGR // BETA —